ClinConnect ClinConnect Logo
Search / Trial NCT06451081

Brief Behavioural Economic Intervention for Smoking Cessation

Launched by THE UNIVERSITY OF HONG KONG · Jun 4, 2024

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

Cessation Tobacco Behavioural Economics Nudge Opt Out

ClinConnect Summary

This clinical trial is looking to see if a short and simple behavioral intervention can help people stop smoking. The researchers want to find out if this approach can encourage smokers in the community to quit. If you live in Hong Kong, are at least 18 years old, and have been smoking daily for the past three months, you might be eligible to participate. You’ll also need to be able to communicate in Chinese and have a smartphone with a messaging app.

If you join the study, you can expect to receive support through this brief intervention aimed at helping you quit smoking. However, if you’re already in another smoking cessation program or using any medications to help quit, you won’t be able to participate. The trial is currently recruiting participants, so it’s a great opportunity to get support in your journey to quit smoking!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Hong Kong residents aged 18 years or above
  • 2. Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
  • 3. Exhaled carbon monoxide level ≥4 parts per million or a positive salivary cotinine test
  • 4. Able to communicate in and read Chinese
  • 5. Own a smartphone with a mobile instant messaging app installed
  • Exclusion Criteria:
  • Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, Hong Kong

Patients applied

0 patients applied

Trial Officials

Tzu Tsun Luk, PhD, RN

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported